These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4616800)

  • 1. Elution of cell-bound anti-prostatic epithelial antibodies after multiple cryotherapy of carcinoma of the prostate.
    Ablin RJ; Gonder MJ; Soanes WA
    Cryobiology; 1974 Jun; 11(3):218-21. PubMed ID: 4616800
    [No Abstract]   [Full Text] [Related]  

  • 2. Elution of in vivo bound antiprostatic epithelial antibodies following multiple cryotherapy of carcinoma of prostate.
    Ablin RJ; Soanes WA; Gonder MJ
    Urology; 1973 Sep; 2(3):276-9. PubMed ID: 4127037
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunohistologic studies of carcinoma of the prostate. 3. Elution of interepithelial antibodies from carcinomatous human prostatic tissue following cryoprostatectomy.
    Ablin RJ; Gonder MJ; Soanes WA
    Oncology; 1974; 29(4):329-34. PubMed ID: 4601846
    [No Abstract]   [Full Text] [Related]  

  • 4. Regression of prostatic cancer following sequential cryotherapy to the prostate.
    Gursel E; Roberts M; Veenema RJ
    J Urol; 1972 Dec; 108(6):928-32. PubMed ID: 4117196
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies reactive with autologous prostatic tissue in adenocarcinoma of prostate.
    Ablin RJ; Danaher J; Soanes WA; Gonder MJ
    Urology; 1974 Apr; 3(4):491-3. PubMed ID: 4595717
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunohistologic studies of carcinoma of the prostate. II. Antibodies to prostatic tissue.
    Ablin RJ; Soanes WA; Danaher J
    Z Immunitatsforsch Exp Klin Immunol; 1972; 142(5):432-8. PubMed ID: 4258921
    [No Abstract]   [Full Text] [Related]  

  • 7. Immuno-cryourogenital treatment of benign and malignant diseases of the prostate.
    Ablin RJ; Soanes WA; Gonder MJ
    Gerontol Clin (Basel); 1970; 12(5):302-13. PubMed ID: 4096938
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic aspects of the prostate.
    Lubaroff DM; Reynolds CW; Canfield L; McElligott D; Feldbush T
    Prostate; 1981; 2(3):233-48. PubMed ID: 6170966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryotherapy in advanced prostatic cancer.
    Gursel EO; Roberts MS; Veenema RJ
    Urology; 1973 May; 1(5):392-6. PubMed ID: 4129676
    [No Abstract]   [Full Text] [Related]  

  • 10. Cryosurgery for prostatic carcinoma.
    Jones LW
    Urology; 1974 Nov; 4(5):499-503. PubMed ID: 4610956
    [No Abstract]   [Full Text] [Related]  

  • 11. Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations.
    Soanes WA; Ablin RJ; Gonder MJ
    J Urol; 1970 Jul; 104(1):154-9. PubMed ID: 4987666
    [No Abstract]   [Full Text] [Related]  

  • 12. Cryoimmunotherapy.
    Ablin RJ
    Br Med J; 1972 Aug; 3(5824):476. PubMed ID: 5069241
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cryotherapy in 141 cases of carcinoma of the prostate reviewed after 5 years (author's transl)].
    Sesia G; De Luca G; Chiaudano C; Cauda F
    J Urol (Paris); 1982; 88(3):155-8. PubMed ID: 7097031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential cryotherapy for prostatic carcinoma: does it palliate the bone pain?
    Horan AH
    Conn Med; 1975 Feb; 39(2):81-3. PubMed ID: 45896
    [No Abstract]   [Full Text] [Related]  

  • 15. B.C.G. immunotherapy in carcinoma of prostate.
    Guinan P; Bush IM; John T; Sadoughi N; Ablin RJ
    Lancet; 1973 Aug; 2(7826):443-4. PubMed ID: 4124919
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological surveillance and -globulin.
    Ablin RJ
    Isr J Med Sci; 1973 Apr; 9(4):480-3. PubMed ID: 4122703
    [No Abstract]   [Full Text] [Related]  

  • 17. The new aspects of immunotherapy in prostate cancer.
    Ghanei M; Shohrati M; Saburi A
    Cancer Immunol Immunother; 2012 Dec; 61(12):2375-6. PubMed ID: 22736256
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and experimental considerations of the immunologic response to prostatic and other accessory glands tissues of reproduction.
    Ablin RJ; Soanes WA; Gonder MJ
    Urol Int; 1970; 25(5):511-39. PubMed ID: 4111980
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum elevation of CEA and CA 19-9 in an aggressive variant of prostatic carcinoma.
    Brandes A; Weinmann M; Reichmann U; Becker G; Gärtner HV; Bamberg M
    Acta Oncol; 2001; 40(7):879-81. PubMed ID: 11859991
    [No Abstract]   [Full Text] [Related]  

  • 20. Adenosquamous carcinoma of the prostate.
    Moyana TN
    Am J Surg Pathol; 1987 May; 11(5):403-7. PubMed ID: 3555133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.